A61K 51/0465
Having six-membered rings with at least one nitrogen and one sulfur as
Official title: {having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame}
A61K51/0465 (Having six-membered rings with at least one nitrogen and one sulfur as) appears on 15 US grants and 28 published applications in this corpus.
Search patents in A61K- Granted patents
- 15
- Published applications
- 28
- Assignees
- 20
- Inventors
- 75
- Latest grant
- 31 May 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 3 |
| 2011 | 1 | 2 |
| 2012 | 1 | 0 |
| 2013 | 1 | 3 |
| 2014 | 1 | 2 |
| 2015 | 2 | 0 |
| 2016 | 0 | 2 |
| 2017 | 1 | 2 |
| 2018 | 0 | 2 |
| 2019 | 2 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Heterocyclic compounds for cancer imaging and treatment and methods for their use31 May 2022US 11,345,670 B2British Columbia Cancer Agency Branch
- Heterocyclic compounds for cancer imaging and treatment and methods for their use19 May 2020US 10,654,811 B2British Columbia Cancer Agency Branch
- Heterocyclic molecules for biomedical imaging and therapeutic applications2 Jul 2019US 10,335,504 B2Washington University
- Alpha-synuclein ligands28 May 2019US 10,300,155 B2Washington University
- Precursor compound connected to solid support for manufacturing 18F radiopharmaceutical, method for manufacturing same, and application thereof5 Sep 2017US 9,751,844 B2Futurechem Co., Ltd.
- Heterocyclic compounds for cancer imaging and treatment and methods for their use28 Nov 2024US 2024/0391883 A1British Columbia Cancer Agency Branch
- Compound and radioactive labeling compound13 Apr 2023US 2023/0112418 A1Kyoto University
- Heterocyclic compounds for cancer imaging and treatment and methods for their use25 Aug 2022US 2022/0267283 A1British Columbia Cancer Agency Branch
- Amyloid-binding compounds and methods of use thereof14 Jan 2021US 2021/0011008 A1Vanderbilt University
- Heterocyclic compounds for cancer imaging and treatment and methods for their use15 Oct 2020US 2020/0325106 A1British Columbia Cancer Agency Branch
Most cited
By later US patents
- Methods of using hepatic-directed compounds in pretargeting strategies36US 5,985,826 ANeoRx Corporation · 1999
- Hepatic-directed compounds and reagents for preparation thereof32US 5,886,143 ANeoRx Corporation · 1999
- Heterocyclic compounds for cancer imaging and treatment and methods for their use11US 10,654,811 B2British Columbia Cancer Agency Branch · 2020
- 3,7-diamino-10H-phenothiazine salts and their use8US 8,710,051 B2Wis Ta Laboratories Ltd. · 2014
- Benzoxazole derivatives7US 7,910,579 B2Tohoku University · 2011